Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder Cancer | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder Cancer Ali Nebioğlu, Rojda Tanrıverdi, Mert Başaranoğlu, Barış Saylam, and 5 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4573841/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 28 Sep, 2024 Read the published version in BMC Urology → Version 1 posted 17 You are reading this latest preprint version Abstract Background: Bladder cancer remains a significant health concern, prompting research into novel biomarkers and treatment strategies. In this study, we aimed to investigate the serum fibronectin levels and gene polymorphisms between patients with NMIBC receiving intravesical BCG treatment and the control group. Methods: Between June 2022 and December 2022, data of 73 patients who applied to the Mersin University Urology Clinic due to NMIBC and were followed and treated in our clinic, receiving intravesical BCG treatment, when necessary, as well as 56 individuals without any malignancy, were prospectively examined. Serum fibronectin levels were measured using the ELISA method. PCR testing was applied for the fibronectin gene RS10202709 and RS 35343655 gene polymorphisms by using Real-Time PCR. Results: The mean serum fibronectin level in the patient group was 76.794±66.998ng/ml. Simultaneously, it was 50.486±25.156ng/ml in the control group, and these differences in serum fibronectin levels were statistically significant(p=0.003). Out of the 73 patients included in the study, recurrence of bladder cancer was observed in 53 of them. They were divided into two groups based on the recurrence times: early recurrence and late recurrence. When examined in terms of fibronectin levels, it was calculated that the mean fibronectin level in the early recurrence group was 102±86.1ng/ml.At the same time,it was 44.7±11.8ng/ml in the late recurrence group (p<0.001). Conclusions: The statistically higher concentrations of serum fibronectin levels in patients with bladder cancer observed in our study are a noteworthy finding.However, we do not anticipate it to be predictive of the response to intravesical BCG treatment.Additionally,the statistically significant findings in our study regarding serum fibronectin level measurements in predicting early and late recurrences suggest that it will provide guiding information about the prognosis of the disease. Trial registration: Ethical approval for the research was obtained from the Mersin University Faculty of Medicine Local Ethics Committee with the decision dated 23.03.2022, numbered 2022/200. BCG Bladder cancer Fibronectin Gene Polymorphism Full Text Additional Declarations Table 1 to 4 are available in the Supplementary Files section. Supplementary Files TAbles2.docx SupplementaryTable1.docx SupplementaryTable2.docx SupplementaryTable3.docx SupplementaryTable4.docx SupplementaryTable5.docx Cite Share Download PDF Status: Published Journal Publication published 28 Sep, 2024 Read the published version in BMC Urology → Version 1 posted Editorial decision: Revision requested 06 Aug, 2024 Reviews received at journal 30 Jul, 2024 Reviews received at journal 22 Jul, 2024 Reviews received at journal 22 Jul, 2024 Reviews received at journal 20 Jul, 2024 Reviewers agreed at journal 18 Jul, 2024 Reviews received at journal 17 Jul, 2024 Reviewers agreed at journal 16 Jul, 2024 Reviewers agreed at journal 16 Jul, 2024 Reviewers agreed at journal 15 Jul, 2024 Reviewers agreed at journal 15 Jul, 2024 Reviewers agreed at journal 15 Jul, 2024 Reviewers invited by journal 15 Jul, 2024 Editor invited by journal 17 Jun, 2024 Editor assigned by journal 17 Jun, 2024 Submission checks completed at journal 17 Jun, 2024 First submitted to journal 13 Jun, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4573841","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":316470625,"identity":"d9b37ef9-4305-4bc6-8252-883ee3a2f75f","order_by":0,"name":"Ali Nebioğlu","email":"","orcid":"","institution":"Mersin City Training and Research Hospital","correspondingAuthor":false,"prefix":"","firstName":"Ali","middleName":"","lastName":"Nebioğlu","suffix":""},{"id":316470626,"identity":"735222e4-c98e-4dd1-8331-8f0b195219a3","order_by":1,"name":"Rojda Tanrıverdi","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Rojda","middleName":"","lastName":"Tanrıverdi","suffix":""},{"id":316470627,"identity":"04b67a6a-624d-4f66-b7a2-d55633bcacc5","order_by":2,"name":"Mert Başaranoğlu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABCElEQVRIiWNgGAWjYJACZgSzgEEORB14gF8HYzOCbcBgDNaSQIqWxAYQjU+Lbnvv88cFNXXy5u1nDz78YnA4fX7Y4YdAW+zkdBuwazE7c9ywecaxw4ZzzuQlG8sYHM7deDvNAKgl2djsAA4tN9IYm3nYDjDOYMgxk5YAaZmdANJyIHEbLi33nwG1/Kuzn8H/Bqwl3XB2+gf8Wm6wMTbztjEnzpDIMZP8YHA4QV46h4AtZ9IYZ8/sO5w8Q+KNsTGDQbrhBumcggMJBnj8cvwYw+eCb3W2M/hzDB/+qLCWl5+dvvnDhwo7OVxaUAAzD5AwAKs0IEI5CDD+ABLyDUSqHgWjYBSMghEDAJGbYphl0vR6AAAAAElFTkSuQmCC","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":true,"prefix":"","firstName":"Mert","middleName":"","lastName":"Başaranoğlu","suffix":""},{"id":316470628,"identity":"d0905d81-020f-47b7-ae0c-ebb73e3d48e0","order_by":3,"name":"Barış Saylam","email":"","orcid":"","institution":"Mersin City Training and Research Hospital","correspondingAuthor":false,"prefix":"","firstName":"Barış","middleName":"","lastName":"Saylam","suffix":""},{"id":316470629,"identity":"e2ee00e0-e4c2-427d-a945-3ea4f6794d9d","order_by":4,"name":"Ercüment Ulusoy","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Ercüment","middleName":"","lastName":"Ulusoy","suffix":""},{"id":316470630,"identity":"839ae82a-3488-4d6c-837a-faf2b4362b5e","order_by":5,"name":"Murat Bozlu","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Murat","middleName":"","lastName":"Bozlu","suffix":""},{"id":316470631,"identity":"911fea8d-cf25-4f05-8422-45c490083be2","order_by":6,"name":"Erdem Akbay","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Erdem","middleName":"","lastName":"Akbay","suffix":""},{"id":316470632,"identity":"8878bcf6-2bab-42f1-ada2-3f53bf1ac31a","order_by":7,"name":"Lülüfer Tamer","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Lülüfer","middleName":"","lastName":"Tamer","suffix":""},{"id":316470633,"identity":"dbb372f8-9881-48ad-bdaf-31c91a2ccf61","order_by":8,"name":"Semra Erdoğan","email":"","orcid":"","institution":"Mersin University Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Semra","middleName":"","lastName":"Erdoğan","suffix":""}],"badges":[],"createdAt":"2024-06-13 06:08:33","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4573841/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4573841/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1186/s12894-024-01592-8","type":"published","date":"2024-09-28T15:57:45+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":65627298,"identity":"7fb07ef1-35cf-4e3c-9398-eefcfd66f28c","added_by":"auto","created_at":"2024-09-30 16:14:28","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":267368,"visible":true,"origin":"","legend":"","description":"","filename":"Manuscript51.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1_covered_1b1ac8d3-ac05-46cf-9bdd-b9959f156ccf.pdf"},{"id":59551884,"identity":"3df35c84-c45c-48c8-aea7-f52c70f00794","added_by":"auto","created_at":"2024-07-03 06:31:43","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":15524,"visible":true,"origin":"","legend":"","description":"","filename":"TAbles2.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/7cb0e7e524b8fcb444989f49.docx"},{"id":59551883,"identity":"4df119ff-f0d9-4076-b240-a3e1e21474dc","added_by":"auto","created_at":"2024-07-03 06:31:42","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":13415,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTable1.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/00d22da8907ad09168a7bf1c.docx"},{"id":59551886,"identity":"3667e847-b557-4bf9-878e-bebe43a5718a","added_by":"auto","created_at":"2024-07-03 06:31:43","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":16424,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTable2.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/490625203624578fa2861bb2.docx"},{"id":59551882,"identity":"674b0740-9525-40f9-b78a-5db58de5c844","added_by":"auto","created_at":"2024-07-03 06:31:42","extension":"docx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":15176,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTable3.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/1a771cd60402a0f24e369e46.docx"},{"id":59551887,"identity":"a8103987-3424-4075-97cb-fe633961e870","added_by":"auto","created_at":"2024-07-03 06:31:43","extension":"docx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":13798,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTable4.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/c32a46663f9d239cd299786e.docx"},{"id":59551885,"identity":"5a1a97b2-c51e-46eb-905f-3e75ce3241b6","added_by":"auto","created_at":"2024-07-03 06:31:43","extension":"docx","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":14559,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTable5.docx","url":"https://assets-eu.researchsquare.com/files/rs-4573841/v1/b0121c0ed25da1579ca43716.docx"}],"financialInterests":"\u003cp\u003eTable 1 to 4 are available in the Supplementary Files section.\u003c/p\u003e","formattedTitle":"Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder Cancer","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"bmc-urology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"buro","sideBox":"Learn more about [BMC Urology](http://bmcurol.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/buro/default.aspx","title":"BMC Urology","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"BCG, Bladder cancer, Fibronectin, Gene Polymorphism","lastPublishedDoi":"10.21203/rs.3.rs-4573841/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4573841/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground: \u003c/strong\u003eBladder cancer remains a significant health concern, prompting research into novel biomarkers and treatment strategies. In this study, we aimed to investigate the serum fibronectin levels and gene polymorphisms between patients with NMIBC receiving intravesical BCG treatment and the control group.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods: \u003c/strong\u003eBetween June 2022 and December 2022, data of 73 patients who applied to the Mersin University Urology Clinic due to NMIBC and were followed and treated in our clinic, receiving intravesical BCG treatment, when necessary, as well as 56 individuals without any malignancy, were prospectively examined. Serum fibronectin levels were measured using the ELISA method. PCR testing was applied for the fibronectin gene RS10202709 and RS 35343655 gene polymorphisms by using Real-Time PCR.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults:\u003c/strong\u003e The mean serum fibronectin level in the patient group was 76.794±66.998ng/ml. Simultaneously, it was 50.486±25.156ng/ml in the control group, and these differences in serum fibronectin levels were statistically significant(p=0.003). Out of the 73 patients included in the study, recurrence of bladder cancer was observed in 53 of them. They were divided into two groups based on the recurrence times: early recurrence and late recurrence. When examined in terms of fibronectin levels, it was calculated that the mean fibronectin level in the early recurrence group was 102±86.1ng/ml.At the same time,it was 44.7±11.8ng/ml in the late recurrence group (p\u0026lt;0.001).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusions:\u003c/strong\u003e The statistically higher concentrations of serum fibronectin levels in patients with bladder cancer observed in our study are a noteworthy finding.However, we do not anticipate it to be predictive of the response to intravesical BCG treatment.Additionally,the statistically significant findings in our study regarding serum fibronectin level measurements in predicting early and late recurrences suggest that it will provide guiding information about the prognosis of the disease.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrial registration: \u003c/strong\u003eEthical approval for the research was obtained from the Mersin University Faculty of Medicine Local Ethics Committee with the decision dated 23.03.2022, numbered 2022/200.\u003c/p\u003e","manuscriptTitle":"Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder Cancer","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-07-03 06:31:37","doi":"10.21203/rs.3.rs-4573841/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-08-06T18:10:40+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-30T09:48:00+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-23T00:30:58+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-22T11:37:46+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-21T03:05:57+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"54974294601343576790102563662555481225","date":"2024-07-18T16:38:42+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-07-17T15:05:47+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"270885158090780780700957790548254106231","date":"2024-07-16T23:57:39+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"268245383159516520189030406558280710161","date":"2024-07-16T12:25:42+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"85750847344800840253161988830713685763","date":"2024-07-15T21:44:31+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"158506938245649189708138227677551344365","date":"2024-07-15T15:50:36+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"284640855669489375271353984519777259800","date":"2024-07-15T12:42:53+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-07-15T12:36:52+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2024-06-17T14:47:31+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-06-17T14:45:59+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-06-17T14:45:41+00:00","index":"","fulltext":""},{"type":"submitted","content":"BMC Urology","date":"2024-06-13T06:07:15+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"bmc-urology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"buro","sideBox":"Learn more about [BMC Urology](http://bmcurol.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/buro/default.aspx","title":"BMC Urology","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"edbd1a7a-b114-46c0-ac82-0bab059bb503","owner":[],"postedDate":"July 3rd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2024-09-30T16:04:41+00:00","versionOfRecord":{"articleIdentity":"rs-4573841","link":"https://doi.org/10.1186/s12894-024-01592-8","journal":{"identity":"bmc-urology","isVorOnly":false,"title":"BMC Urology"},"publishedOn":"2024-09-28 15:57:45","publishedOnDateReadable":"September 28th, 2024"},"versionCreatedAt":"2024-07-03 06:31:37","video":"","vorDoi":"10.1186/s12894-024-01592-8","vorDoiUrl":"https://doi.org/10.1186/s12894-024-01592-8","workflowStages":[]},"version":"v1","identity":"rs-4573841","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4573841","identity":"rs-4573841","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.